Abstract:AdipoRon, a small-molecule adiponectin receptor (AdipoR) agonist, has been reported to be implicated in cardiovascular diseases. However, its role in pressure-overload-induced cardiac remodeling is still elusive. To elucidate the role of AdipoRon in the pathogenesis of cardiac remodeling in vivo and vitro, in the left ventricle of human end-stage heart failure, the expression of AdipoR2 is upregulated. Meanwhile, increased expression of AdipoR2 was also observed in mice failing hearts. Oral administration of AdipoRon alleviated cardiac hypertrophy and fibrosis induced by pressure overload, as evidenced by the beneficial change of cross-sectional area of cardiomyocytes, heart weight-to-body weight ratio, gene expression of hypertrophic markers, ventricle collagen ratio, and cardiac function. The AMPKα activation mediated by AdipoRon significantly inhibited AngII-induced TGF-β1 expression and cardiac fibroblast differentiation, and these inhibitory effects were abrogated by treatment with the AMPK inhibitor Compound C. Consistent with the above results, AdipoRon abolished the ability to retard AngII-induced TGF-β1 expression in AMPKα2 −/− cardiac fibroblasts. In AMPKα2 −/− mice subjected to aortic banding, AdipoRon abolished the protective effect, as indicated by increased cross-sectional area, cardiac collagen ratio, and cardiac dysfunction. Our results demonstrated that AdipoR2 expression was markedly increased in the failing hearts. AdipoRon inhibited TGF-β1 expression and myofibroblast differentiation in AMPKα-dependent manner in vitro. In line with the vitro results, AMPKα2 −/− mice markedly abrogated the inhibitory effects of AdipoRon in cardiac remodeling. These results indicated AdipoRon may hold promise of an effective therapy against pressure-overload-induced cardiac remodeling. Key messages • The increased expression of AdipoR2 is observed in human and mice failing hearts, the changeable expression of AdipoR suggests the possible role of AdipoR in cardiac remodeling. • Oral administration of AdipoRon alleviates cardiac hypertrophy and fibrosis induced by pressure overload, and AMPKα activation mediated by AdipoRon significantly inhibited AngII-induced TGF-β1 expression and cardiac fibroblast differentiation. • These findings provide new mechanistic insight and open new therapeutic pathways for heart failure.

Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta Constriction

Adiponectin Regulates Bone Marrow Mesenchymal Stem Cell Niche Through a Unique Signal Transduction Pathway: an Approach for Treating Bone Disease in Diabetes

Effect of adiponectin on obesity-linked diseases

Adiponectin Deficiency Accentuates High Fat Diet‐Induced Cardiac Hypertrophy and Contractile Dysfunction Through Regulation of Autophagy

Adiponectin Knockout Accentuates High Fat Diet-Induced Obesity and Cardiac Dysfunction: Role of Autophagy

Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model

Adiponectin Regulates SR Ca(2+) Cycling Following Ischemia/reperfusion Via Sphingosine 1-Phosphate-camkii Signaling in Mice.

Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway

Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders

GW24-e3646 Adiponectin regulates SR Ca2+cycling following ischaemia/reperfusion through sphingosine 1-phosphate-CaMKII signalling in mice

AMPK attenuates ventricular remodeling and dysfunction following aortic banding in mice via the Sirt3/Oxidative stress pathway

Adiponectin Improves Cardiomyocyte Contractile Function In Db/Db Diabetic Obese Mice

AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload

Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction

Central Adiponectin Administration Reveals New Regulatory Mechanisms of Bone Metabolism in Mice.

Permissive Role of AMPK and Autophagy in Adiponectin Deficiency-Accentuated Myocardial Injury and Inflammation in Endotoxemia.

Atrial Natriuretic Peptide Ameloriates Diabetic Cardiomyopathy in Insulin-Deficient Rats in Vivo

[Effects of Gadol and Ganoderma spores on the adiponectin signal pathway in hypertrophic myocardium of spontaneous hypertensive rats]

Adiponectin promotes preadipocyte differentiation via the PPARγ pathway

[Effect of AMP-activated Protein Kinase on Cardiovascular Protection of Adiponectin].

Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice